S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead

C4 Therapeutics (CCCC) SEC Filings & 10K Form

$6.86
-0.55 (-7.42%)
(As of 04/15/2024 ET)

Recent C4 Therapeutics SEC Filings

DateFilerForm TypeView
04/10/2024
3:16 PM
C4 Therapeutics (Issuer)
Mossler Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/10/2024
8:52 AM
C4 Therapeutics (Subject)
STATE STREET CORP (Filed by)
Form SC 13G
03/08/2024
6:28 PM
Boyle Scott N (Reporting)
C4 Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
6:19 PM
C4 Therapeutics (Issuer)
Siegel Jolie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
6:21 PM
Adams Kendra (Reporting)
C4 Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
6:24 PM
C4 Therapeutics (Issuer)
Schick Kelly (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
6:26 PM
C4 Therapeutics (Issuer)
Fisher Stewart (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
12:11 PM
C4 Therapeutics (Subject)
WASATCH ADVISORS LP (Filed by)
Form SC 13G/A
03/04/2024
6:05 AM
C4 Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/22/2024
8:01 AM
C4 Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/22/2024
6:15 AM
C4 Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/22/2024
6:20 AM
C4 Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/15/2024
5:18 PM
C4 Therapeutics (Issuer)
Hirsch Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
8:21 AM
C4 Therapeutics (Subject)
Lynx1 Capital Management LP (Filed by)
Form SC 13G/A
02/14/2024
6:35 AM
C4 Therapeutics (Subject)
RTW INVESTMENTS, LP (Filed by)
Form SC 13G/A
02/09/2024
12:04 PM
C4 Therapeutics (Subject)
WASATCH ADVISORS LP (Filed by)
Form SC 13G/A
02/05/2024
9:24 AM
C4 Therapeutics (Subject)
Soleus Capital Master Fund, L.P. (Filed by)
Form SC 13G
02/02/2024
8:34 AM
C4 Therapeutics (Subject)
Soleus Capital Master Fund, L.P. (Filed by)
Form SC 13G/A
01/12/2024
3:01 PM
Betta Investment Ltd. (0001990727) (Filed by)
C4 Therapeutics (Subject)
Form SC 13G
01/11/2024
6:05 AM
C4 Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/04/2024
3:15 PM
C4 Therapeutics (Subject)
Point72 Asset Management, L.P. (Filed by)
Form SC 13G
01/03/2024
3:12 PM
C4 Therapeutics (Issuer)
Dubin Glenn (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2023
3:30 PM
C4 Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SC 13G
12/22/2023
3:05 PM
C4 Therapeutics (Subject)
COMMODORE CAPITAL LP (Filed by)
Form SC 13G
12/12/2023
3:28 PM
C4 Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/12/2023
6:15 AM
C4 Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/20/2023
3:21 PM
C4 Therapeutics (Issuer)
Hughes Owen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2023
3:18 PM
C4 Therapeutics (Issuer)
Hughes Owen (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/20/2023
6:05 AM
C4 Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/01/2023
6:31 AM
C4 Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/01/2023
6:18 AM
C4 Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/03/2023
3:26 PM
C4 Therapeutics (Issuer)
GROGAN DONNA ROY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2023
3:27 PM
C4 Therapeutics (Issuer)
Dubin Glenn (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2023
3:28 PM
Anderson Kenneth Carl (Reporting)
C4 Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/19/2023
6:20 PM
Adams Kendra (Reporting)
C4 Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/19/2023
6:20 PM
C4 Therapeutics (Issuer)
Mossler Mark (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/19/2023
6:21 PM
Adams Kendra (Reporting)
C4 Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/19/2023
6:22 PM
C4 Therapeutics (Issuer)
Siegel Jolie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/19/2023
6:23 PM
Boyle Scott N (Reporting)
C4 Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/19/2023
6:23 PM
C4 Therapeutics (Issuer)
Fisher Stewart (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/19/2023
6:23 PM
C4 Therapeutics (Issuer)
Schick Kelly (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Nerd Investor Reveals Secret To Make Money With A.I. (Ad)

He's doing something he's never done before. In ten years, this nerd investor has picked 210+ stocks that have gone up at least 100%.

>>Check out what this A.I. Perfect Storm is<<
09/19/2023
6:24 PM
C4 Therapeutics (Issuer)
Hirsch Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2023
6:16 AM
C4 Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/08/2023
6:09 AM
C4 Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/12/2023
3:05 PM
C4 Therapeutics (Issuer)
REYNO LEONARD (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/12/2023
3:06 PM
C4 Therapeutics (Issuer)
REYNO LEONARD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/07/2023
3:35 PM
BlackRock Inc. (Filed by)
C4 Therapeutics (Subject)
Form SC 13G/A
06/20/2023
6:11 AM
C4 Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/16/2023
3:22 PM
C4 Therapeutics (Issuer)
Salter Malcolm (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2023
3:22 PM
C4 Therapeutics (Issuer)
Koppikar Utpal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2023
3:23 PM
C4 Therapeutics (Issuer)
GROGAN DONNA ROY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2023
3:23 PM
C4 Therapeutics (Issuer)
Dubin Glenn (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2023
3:24 PM
C4 Therapeutics (Issuer)
DOWNEY BRUCE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2023
3:24 PM
Bessen Laura (Reporting)
C4 Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2023
3:25 PM
Anderson Kenneth Carl (Reporting)
C4 Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2023
6:30 AM
C4 Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/04/2023
6:46 AM
C4 Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/04/2023
6:34 AM
C4 Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/03/2023
11:15 PM
C4 Therapeutics (Filer)
Form EFFECT
04/28/2023
6:01 AM
C4 Therapeutics (Filer)
Form DEF 14A
04/28/2023
6:02 AM
C4 Therapeutics (Filer)
Form DEFA14A
04/28/2023
6:03 AM
C4 Therapeutics (Filer)
Form ARS
04/18/2023
6:59 AM
C4 Therapeutics (Filer)
Form PRE 14A
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:CCCC) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners